Request a copy of the file

Enter the following information to request a copy for the following item: Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Requesting the following file: BaselgaJLancetOncol2017.pdf